Overview

A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product

Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To assess the bioequivalence of esomeprazole of the TEST product vs. the REFERENCE product in healthy volunteers who reside in Taiwan.
Phase:
Phase 4
Details
Lead Sponsor:
isRed Pharma & Biotech Research Corporation
Collaborator:
Yung Shin Pharmaceutical Ind. Co., Ltd.
Treatments:
Esomeprazole